Search





Search





Markets
/
Stocks
/
dnli
/

Denali Therapeutics Inc

DNLI

Add to Watchlist

24.040USD

+0.470+1.99%

Close 07-27 16:00（ET）Quotes delayed by 15 min

3.81BMarket Cap

LossP/E TTM

Denali Therapeutics Inc

24.040

+0.470+1.99%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

DNLI Cash Flow Statement

You can access the annual and quarterly cash flow statements of Denali Therapeutics Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

FY2017Q4

FY2017Q3

FY2017Q1

FY2016Q4

FY2016Q3

Operating cash flows (indirect method)

Cash flow from continuing operating activities

0.20%-131.20M

-17.71%-98.54M

-81.43%-107.30M

17.45%-75.30M

-15.71%-131.47M

15.15%-83.72M

32.31%-59.14M

19.39%-91.22M

-93.22%-113.62M

-35.77%-98.66M

-53.14%-87.36M

-163.81%-113.17M

18.45%-58.80M

-10.95%-72.66M

-37.68%-57.05M

20.88%-42.90M

-43.53%-72.11M

-112.74%-65.49M

-48279.07%-41.43M

-25.06%-54.22M

7.80%-50.24M

1178.68%513.91M

100.28%86.00K

-0.42%-43.36M

-79.71%-54.49M

-151.13%-47.64M

12.60%-30.43M

-3.23%-43.17M

-190.31%-30.32M

608.21%93.19M

-58.85%-34.82M

---41.82M

278.52%33.58M

0.16%-18.34M

-2.98%-21.92M

---18.81M

---18.37M

---21.29M

Net income from continuing operations

3.40%-128.45M

-12.02%-128.55M

-18.39%-126.90M

-25.34%-124.12M

-30.62%-132.97M

3.95%-114.75M

-7.89%-107.19M

-154.00%-99.03M

7.27%-101.80M

-21.07%-119.47M

3.82%-99.35M

411.91%183.38M

-68.32%-109.78M

-31.11%-98.68M

-22.12%-103.30M

3.13%-58.79M

6.88%-65.22M

-130.73%-75.26M

-45.27%-84.59M

-3.29%-60.69M

-23.39%-70.04M

553.28%244.88M

-25.87%-58.23M

-0.72%-58.76M

-45.58%-56.76M

-169.68%-54.02M

-30.79%-46.26M

-6.60%-58.34M

-64.68%-38.99M

438.76%77.53M

-61.93%-35.37M

---54.72M

-11.06%-23.68M

-18.25%-22.89M

28.64%-21.84M

---21.32M

---19.35M

---30.61M

Operating gains losses

17.09%3.76M

44.41%3.78M

70.21%3.86M

103.71%3.96M

48.57%3.21M

20.30%2.62M

2.35%2.27M

-15.01%1.94M

-78.48%2.16M

-46.79%2.18M

3.55%2.22M

10.28%2.29M

383.26%10.05M

95.37%4.09M

-2.10%2.14M

-5.99%2.07M

-1.38%2.08M

-1.27%2.09M

1.44%2.19M

2.75%2.20M

-0.05%2.11M

3.21%2.12M

14.07%2.16M

30.55%2.15M

-12.23%2.11M

-13.62%2.06M

-18.78%1.89M

-11.43%1.64M

181.38%2.40M

194.80%2.38M

199.10%2.33M

--1.85M

16.83%854.00K

17.64%807.00K

94.01%778.00K

--731.00K

--686.00K

--401.00K

Other non-cash items

57.28%-2.11M

62.05%-2.74M

66.37%-3.17M

65.61%-3.81M

56.97%-4.94M

45.34%-7.21M

29.01%-9.43M

11.11%-11.08M

-31.42%-11.47M

-236.86%-13.20M

-781.22%-13.28M

-3522.38%-12.46M

-1134.36%-8.73M

-184.57%-3.92M

-180.24%-1.51M

-119.45%-344.00K

80.34%844.00K

64.41%4.63M

374.96%1.88M

203.88%1.77M

238.05%468.00K

218.40%2.82M

16.61%-683.00K

-35.70%-1.70M

-551.92%-339.00K

-183.00%-2.38M

-6.09%-819.00K

-78.01%-1.25M

86.56%-52.00K

-476.03%-841.00K

-460.75%-772.00K

---705.00K

-270.48%-387.00K

-191.25%-146.00K

-96.05%214.00K

--227.00K

--160.00K

--5.42M

Change in working capital

-25.36%-27.50M

-52.48%5.02M

-120.50%-6.22M

385.41%23.29M

-38.73%-21.93M

80.46%10.55M

788.70%30.35M

97.39%-8.16M

-173.27%-15.81M

792.98%5.85M

-120.95%-4.41M

-3103.79%-312.95M

160.01%21.58M

103.44%655.00K

16.30%21.04M

47.59%-9.77M

-845.49%-35.96M

-107.61%-19.05M

-58.50%18.09M

-853.09%-18.64M

63.02%-3.80M

11569.34%250.26M

644.73%43.59M

133.49%2.48M

-1749.64%-10.28M

-125.77%-2.18M

189.83%5.85M

-84.93%1.06M

-101.03%-556.00K

248.05%8.47M

-196.45%-6.52M

--7.03M

6740.99%53.91M

540.76%2.43M

-193.97%-2.20M

--788.00K

---552.00K

--2.34M

-Change in prepaid expenses

91.99%-2.29M

1104.83%1.75M

-92.30%1.36M

1689.62%24.96M

-52.44%-28.61M

102.42%145.00K

20257.47%17.71M

-143.47%-1.57M

-948.97%-18.77M

-336.97%-6.00M

-99.35%87.00K

122.58%3.61M

-244.04%-1.79M

93.43%-1.37M

-17.01%13.37M

-11.40%-15.99M

-80.29%1.24M

-45.36%-20.91M

64316.00%16.10M

-329.77%-14.36M

356.76%6.30M

-1767.21%-14.39M

-99.20%25.00K

4408.97%6.25M

-186.14%-2.45M

106.68%863.00K

184.89%3.11M

-38.10%-145.00K

276.63%2.85M

-17088.16%-12.91M

-188.49%-3.66M

---105.00K

-182.34%-1.61M

105.84%76.00K

-343.10%-1.27M

--1.96M

---1.30M

--522.00K

-Change in other current assets

25.77%-700.00K

-129.93%-533.00K

-45.76%-1.72M

--3.96M

---943.00K

--1.78M

---1.18M

----

--0.00

----

--0.00

-Change in other current liabilities

-135.77%-5.99M

-39.88%-5.52M

-193.48%-3.69M

---557.00K

--16.73M

-940.63%-3.94M

411.04%3.94M

100.00%0.00

-33.92%-379.00K

64.37%-1.27M

-60259.71%-289.12M

99.53%-141.00K

90.02%-283.00K

32.67%-3.56M

93.97%-479.00K

-39244.16%-30.14M

-101.13%-2.84M

-114.86%-5.29M

-42.39%-7.94M

102.51%77.00K

7309.89%251.55M

3112.53%35.58M

-564.48%-5.58M

-294.98%-3.07M

-120.93%-3.49M

-13.78%-1.18M

69.62%-839.00K

-101.30%-777.00K

7474.34%16.67M

-574.03%-1.04M

---2.76M

12089.39%59.73M

-128.28%-226.00K

-36.28%-154.00K

--490.00K

---99.00K

---113.00K

Cash from non-recurring investing activities

Cash from operating activities

0.20%-131.20M

-17.71%-98.54M

-81.43%-107.30M

17.45%-75.30M

-15.71%-131.47M

15.15%-83.72M

32.31%-59.14M

19.39%-91.22M

-93.22%-113.62M

-35.77%-98.66M

-53.14%-87.36M

-163.81%-113.17M

18.45%-58.80M

-10.95%-72.66M

-37.68%-57.05M

20.88%-42.90M

-43.53%-72.11M

-112.74%-65.49M

-48279.07%-41.43M

-25.06%-54.22M

7.80%-50.24M

1178.68%513.91M

100.28%86.00K

-0.42%-43.36M

-79.71%-54.49M

-151.13%-47.64M

12.60%-30.43M

-3.23%-43.17M

-190.31%-30.32M

608.21%93.19M

-58.85%-34.82M

---41.82M

278.52%33.58M

0.16%-18.34M

-2.98%-21.92M

---18.81M

---18.37M

---21.29M

Investing cash flow

Net cash from continuing investing activities

-51.44%2.47M

-70.07%1.52M

-135.48%-1.38M

-10.61%4.28M

136.19%5.08M

127.83%5.09M

87.81%3.88M

-18.19%4.79M

-22.83%2.15M

-53.91%2.23M

-65.82%2.07M

102.21%5.85M

-31.06%2.79M

58.83%4.85M

222.67%6.05M

274.74%2.89M

44.32%4.04M

155.48%3.05M

165.58%1.88M

145.08%772.00K

218.54%2.80M

-56.91%1.20M

-75.20%706.00K

-96.93%315.00K

-56.66%879.00K

92.97%2.77M

236.13%2.85M

1695.63%10.27M

277.65%2.03M

34.17%1.44M

130.79%847.00K

--572.00K

-38.13%537.00K

-53.70%1.07M

-84.31%367.00K

--868.00K

--2.31M

--2.34M

Capital expenditures

-51.44%2.47M

-70.07%1.52M

----

-10.61%4.28M

136.19%5.08M

127.83%5.09M

87.81%3.88M

-18.19%4.79M

-22.83%2.15M

-53.91%2.23M

-65.82%2.07M

102.21%5.85M

-31.06%2.79M

58.83%4.85M

222.67%6.05M

274.74%2.89M

44.32%4.04M

155.48%3.05M

165.58%1.88M

145.08%772.00K

218.54%2.80M

-56.91%1.20M

-75.20%706.00K

-96.93%315.00K

-56.66%879.00K

92.97%2.77M

236.13%2.85M

1695.63%10.27M

277.65%2.03M

34.17%1.44M

130.79%847.00K

--572.00K

-38.13%537.00K

-53.70%1.07M

-84.31%367.00K

--868.00K

--2.31M

--2.34M

Net cash flow from disposal of fixed assets

-51.44%2.47M

-70.07%1.52M

-135.48%-1.38M

-10.61%4.28M

136.19%5.08M

127.83%5.09M

87.81%3.88M

-18.19%4.79M

-22.83%2.15M

-53.91%2.23M

-65.82%2.07M

102.21%5.85M

-31.06%2.79M

58.83%4.85M

222.67%6.05M

274.74%2.89M

44.32%4.04M

155.48%3.05M

165.58%1.88M

145.08%772.00K

218.54%2.80M

-56.91%1.20M

-75.20%706.00K

-96.93%315.00K

-56.66%879.00K

92.97%2.77M

236.13%2.85M

1695.63%10.27M

277.65%2.03M

34.17%1.44M

130.79%847.00K

--572.00K

-38.13%537.00K

-53.70%1.07M

-84.31%367.00K

--868.00K

--2.31M

--2.34M

Net cash flow from investment products

306.81%96.93M

-87.43%22.29M

-42.12%56.45M

56.95%162.21M

105.28%23.83M

135.51%177.30M

-5.28%97.54M

-40.57%103.36M

-401.55%-451.04M

161.35%75.28M

379.65%102.98M

90.02%173.92M

21.00%-89.93M

-225.52%-122.71M

141.99%21.47M

-6.90%91.52M

-403.59%-113.84M

89.70%-37.70M

75.81%-51.13M

426.65%98.31M

-81.51%-22.61M

-910.81%-366.14M

-503.93%-211.42M

-140.59%-30.10M

-106.91%-12.45M

175.31%45.16M

14.85%52.34M

138.43%74.15M

98.00%-6.02M

36.26%-59.97M

169.78%45.57M

--31.10M

-1950.58%-300.74M

-465.58%-94.08M

111.49%16.89M

--16.25M

---16.63M

---146.97M

Net cash flow from other investing activities

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

403.84%94.46M

-87.94%20.77M

-38.25%57.83M

60.23%157.94M

104.14%18.75M

135.75%172.21M

-7.19%93.66M

-41.35%98.57M

-388.80%-453.19M

157.27%73.05M

554.45%100.91M

89.63%168.07M

21.35%-92.72M

-213.03%-127.56M

129.09%15.42M

-9.13%88.63M

-364.00%-117.88M

88.91%-40.75M

75.01%-53.01M

420.73%97.54M

-90.54%-25.41M

-966.67%-367.34M

-528.59%-212.12M

-147.61%-30.41M

-65.69%-13.33M

169.03%42.38M

10.66%49.49M

109.25%63.88M

97.33%-8.05M

35.47%-61.40M

170.65%44.73M

--30.53M

-2058.49%-301.27M

-402.19%-95.15M

111.07%16.53M

--15.38M

---18.95M

---149.31M

Financing cash flow

Cash flow from continuous financing activities

5922.54%219.04M

4709.72%192.13M

95.81%-778.00K

-75.98%1.62M

-100.75%-3.76M

-188.59%-4.17M

-844.74%-18.56M

-25.09%6.76M

31089.21%500.27M

-98.43%4.71M

-51.65%2.49M

104.88%9.02M

9.64%1.60M

5698.20%299.65M

55.48%5.15M

-37.50%4.40M

-61.72%1.46M

-45.73%5.17M

-99.22%3.31M

106.24%7.04M

-98.05%3.82M

368.14%9.52M

62624.45%425.90M

32.93%3.42M

21476.32%195.91M

20.36%2.03M

3.19%679.00K

79.40%2.57M

-99.03%908.00K

-99.43%1.69M

84.31%658.00K

--1.43M

28677.47%93.24M

7389875.00%295.59M

-95.36%357.00K

--324.00K

---4.00K

--7.69M

Net cash flow from debt Issuance/repayment

99.61%-17.00K

99.81%-16.00K

94.33%-1.36M

---2.43M

---4.36M

---8.32M

---24.02M

----

--0.00

----

Net cash flow from common stock issuance/repurchase

--12.37M

--189.25M

--0.00

-100.00%0.00

--0.00

--499.25M

----

--296.21M

----

--0.00

-100.00%0.00

--0.00

-100.00%0.00

--0.00

--420.15M

--0.00

--193.95M

--0.00

-100.00%0.00

--0.00

--1.34M

--93.06M

--265.62M

----

--0.00

----

Net cash flow from preferred stock issuance/repurchase

----

--29.97M

-100.00%0.00

----

--7.62M

Proceeds from stock option exercised by employees

1025.21%6.70M

-22.41%3.22M

-89.31%583.00K

-39.95%4.06M

-41.78%595.00K

-11.69%4.16M

118.94%5.46M

-25.09%6.76M

-36.28%1.02M

36.93%4.71M

-51.65%2.49M

104.88%9.02M

9.64%1.60M

-33.51%3.44M

55.48%5.15M

-37.50%4.40M

-61.72%1.46M

-45.73%5.17M

-42.38%3.31M

106.24%7.04M

94.50%3.82M

368.14%9.52M

747.28%5.75M

32.93%3.42M

116.41%1.96M

20.36%2.03M

3.19%679.00K

79.40%2.57M

314.61%908.00K

168900.00%1.69M

84.31%658.00K

--1.43M

-32.41%219.00K

125.00%1.00K

402.82%357.00K

--324.00K

---4.00K

--71.00K

Net cash flow from other financing activities

--200.00M

---324.00K

--0.00

----

--0.00

100.00%0.00

--0.00

---1.34M

---44.00K

----

--0.00

----

Net cash from non-recurrent financing activities

Net cash from financing activities

5922.54%219.04M

4709.72%192.13M

95.81%-778.00K

-75.98%1.62M

-100.75%-3.76M

-188.59%-4.17M

-844.74%-18.56M

-25.09%6.76M

31089.21%500.27M

-98.43%4.71M

-51.65%2.49M

104.88%9.02M

9.64%1.60M

5698.20%299.65M

55.48%5.15M

-37.50%4.40M

-61.72%1.46M

-45.73%5.17M

-99.22%3.31M

106.24%7.04M

-98.05%3.82M

368.14%9.52M

62624.45%425.90M

32.93%3.42M

21476.32%195.91M

20.36%2.03M

3.19%679.00K

79.40%2.57M

-99.03%908.00K

-99.43%1.69M

84.31%658.00K

--1.43M

28677.47%93.24M

7389875.00%295.59M

-95.36%357.00K

--324.00K

---4.00K

--7.69M

Net cash flow

Beginning cash balance

18.07%208.43M

2.01%94.07M

89.25%144.31M

-3.37%60.05M

37.19%176.53M

-38.36%92.21M

-42.90%76.25M

-10.75%62.15M

-41.39%128.68M

24.54%149.59M

-14.71%133.55M

-34.59%69.63M

-25.57%219.54M

-69.67%120.11M

-67.86%156.59M

-75.63%106.45M

-42.01%294.98M

12.34%396.05M

251.29%487.18M

108.97%436.82M

528.35%508.64M

318.84%352.55M

115.23%138.68M

407.85%209.04M

2.96%80.95M

86.43%84.17M

86.30%64.44M

-7.40%41.16M

-64.08%78.62M

24.49%45.15M

-16.27%34.59M

--44.45M

442.02%218.91M

-53.00%36.27M

-82.79%41.31M

--40.39M

--77.17M

--240.07M

Current period cash flow changes

256.50%182.30M

35.62%114.36M

-414.87%-50.24M

497.38%84.26M

-75.08%-116.48M

503.37%84.32M

-0.51%15.96M

-77.93%14.11M

55.62%-66.53M

-121.03%-20.91M

143.97%16.04M

27.49%63.92M

20.48%-149.91M

198.37%99.43M

59.98%-36.47M

-0.44%50.13M

-162.48%-188.52M

-164.75%-101.08M

-142.61%-91.13M

171.58%50.36M

-156.07%-71.82M

4941.72%156.10M

983.56%213.86M

-402.27%-70.35M

441.91%128.09M

-109.63%-3.22M

86.85%19.74M

335.96%23.27M

78.53%-37.46M

-81.62%33.47M

309.67%10.56M

---9.86M

-5524.05%-174.46M

588.00%182.11M

96.91%-5.04M

---3.10M

---37.32M

---162.90M

Ending cash balance

550.65%390.73M

18.07%208.43M

2.01%94.07M

89.25%144.31M

-3.37%60.05M

37.19%176.53M

-38.36%92.21M

-42.90%76.25M

-10.75%62.15M

-41.39%128.68M

24.54%149.59M

-14.71%133.55M

-34.59%69.63M

-25.57%219.54M

-69.67%120.11M

-67.86%156.59M

-75.63%106.45M

-42.01%294.98M

12.34%396.05M

251.29%487.18M

108.97%436.82M

528.35%508.64M

318.84%352.55M

115.23%138.68M

407.85%209.04M

2.96%80.95M

86.43%84.17M

86.30%64.44M

-7.40%41.16M

-64.00%78.62M

24.49%45.15M

--34.59M

19.22%44.45M

447.95%218.38M

-53.00%36.27M

--37.29M

--39.85M

--77.17M

Free cash flow

2.11%-133.67M

-12.67%-100.06M

----

17.11%-79.58M

-17.95%-136.55M

11.98%-88.81M

29.53%-63.02M

19.34%-96.01M

-87.97%-115.77M

-30.16%-100.89M

-41.74%-89.43M

-159.92%-119.02M

19.12%-61.59M

-13.08%-77.51M

-45.69%-63.10M

16.73%-45.79M

-43.57%-76.15M

-113.37%-68.55M

-6885.32%-43.31M

-25.92%-54.99M

4.21%-53.04M

1116.98%512.72M

98.14%-620.00K

18.29%-43.67M

-71.16%-55.37M

-154.95%-50.42M

6.69%-33.28M

-26.06%-53.45M

-197.91%-32.35M

572.76%91.75M

-60.04%-35.67M

---42.40M

267.91%33.04M

6.15%-19.41M

5.66%-22.29M

---19.68M

---20.68M

---23.63M

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Denali Therapeutics Inc Generate?



Denali Therapeutics Inc generated -412.60M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Denali Therapeutics Inc's Operating Cash Flow Change Year Over Year?



Denali Therapeutics Inc's operating cash flow increased by -18.67% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Denali Therapeutics Inc Spend on Capital Expenditures?



Denali Therapeutics Inc spent 9.50M on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Denali Therapeutics Inc's Financing Cash Flow Changed?



Denali Therapeutics Inc used 189.22M in financing activities in the latest quarter.

What is free cash flow and why does it matter for DNLI?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Denali Therapeutics Inc’s free cash flow in the latest quarter?



Free cash flow was -422.10M reflecting a -16.09% change from the previous year.